Morgan Stanley’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.2M | Buy |
|
|||||
|
2025
Q1 | $27.4M | Sell |
|
|||||
|
2024
Q4 | $38.9M | Buy |
|
|||||
|
2024
Q3 | $38.9M | Buy |
|
|||||
|
2024
Q2 | $34.5M | Buy |
|
|||||
|
2024
Q1 | $26.7M | Sell |
|
|||||
|
2023
Q4 | $75.2M | Buy |
|
|||||
|
2023
Q3 | $45.2M | Sell |
|
|||||
|
2023
Q2 | $43.9M | Buy |
|
|||||
|
2023
Q1 | $20.3M | Buy |
|
|||||
|
2022
Q4 | $18.9M | Sell |
|
|||||
|
2022
Q3 | $26.4M | Sell |
|
|||||
|
2022
Q2 | $24.1M | Sell |
|
|||||
|
2022
Q1 | $27.9M | Buy |
|
|||||
|
2021
Q4 | $23.3M | Buy |
|
|||||
|
2021
Q3 | $13.8M | Sell |
|
|||||
|
2021
Q2 | $45.9M | Buy |
|
|||||
|
2021
Q1 | $64.3M | Sell |
|
|||||
|
2020
Q4 | $82.5M | Sell |
|
|||||
|
2020
Q3 | $62.3M | Buy |
|
|||||
|
2020
Q2 | $39.7M | Buy |
|
|||||
|
2020
Q1 | $4.88M | Sell |
|
|||||
|
2019
Q4 | $46M | Buy |
|
|||||
|
2019
Q3 | $8.31M | Buy |
|
|||||
|
2019
Q2 | $6.29M | Sell |
|
|||||
|
2019
Q1 | $25.8M | Buy |
|
|||||
|
2018
Q4 | $17.1M | Sell |
|
|||||
|
2018
Q3 | $30.8M | Sell |
|
|||||
|
2018
Q2 | $33.4M | Buy |
|
|||||
|
2018
Q1 | $11.9M | Sell |
|
|||||
|
2017
Q4 | $11.4M | Buy |
|
|||||
|
2017
Q3 | $4.07M | Sell |
|
|||||
|
2017
Q2 | $12.3M | Buy |
|
|||||
|
2017
Q1 | $3.27M | Sell |
|
|||||
|
2016
Q4 | $6.56M | Buy |
|
|||||
|
2016
Q3 | $1.28M | Sell |
|
|||||
|
2016
Q2 | $1.85M | Buy |
|
|||||
|
2016
Q1 | $509K | Sell |
|
|||||
|
2015
Q4 | $3.39M | Sell |
|
|||||
|
2015
Q3 | $6.95M | Buy |
|
|||||
|
2015
Q2 | $1.96M | Buy |
|
|||||
|
2015
Q1 | $1.64M | Buy |
|
|||||
|
2014
Q4 | $704K | Sell |
|
|||||
|
2014
Q3 | $1.11M | Buy |
|
|||||
|
2014
Q2 | $969K | Sell |
|
|||||
|
2014
Q1 | $4.55M | Buy |
|
|||||
|
2013
Q4 | $773K | Sell |
|
|||||
|
2013
Q3 | $986K | Sell |
|
|||||
|
2013
Q2 | $2.72M | Buy |
|